Clinical Trial Update: Matrix Metalloproteinases and Diabetic Nephropathy

View source ↗

Summary

The clinical trial investigating matrix metalloproteinases in diabetic nephropathy has completed, involving participants with Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 1 Diabetes Mellitus

Snippet

Sponsor: Arkansas Children's Hospital Research Institute | Conditions: Diabetes Mellitus, Type 1, Diabetic Nephropathy | Status: COMPLETED